Redeye: Binero - Steps in the right direction
Redeye retains its positive view of Binero following the Q4 2022 report. The sales exceeded our expectations, which, despite higher-than-expected operating expenses, led to a stronger EBITDA than anticipated. Accordingly, we make forecast adjustments that have a slight upward effect on our fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/